Table 1 England (1999–2011): number of people in the study with each immune-mediated disease, and percentage who were female
From: Associations between selected immune-mediated diseases and tuberculosis: record-linkage studies
Immune-mediated diseases (ICD-10 codes) and reference | N | Female (%) |
|---|---|---|
Addison’s disease (E27.1) [3] | 12,506 | 60.0 |
Ankylosing spondylitis (M45) [7] | 30,281 | 30.4 |
Autoimmune hemolytic anemia (D59.1) [8] | 9,696 | 54.0 |
Chronic active hepatitis (K73.2) | 4,761 | 70.0 |
Crohn’s disease (K50) [9] | 137,432 | 55.9 |
Coeliac disease (K90.0) [4] | 70,300 | 66.5 |
Dermatomyositis (M33.0 to M33.1) [10] | 2,903 | 67.1 |
Polymyositis (M33.2) [10] | 4,130 | 62.3 |
Goodpasture’s syndrome (M31.0) [11] | 1,157 | 49.5 |
Hashimoto’s thyroiditis (E06.3) | 8,571 | 90.6 |
Idiopathic thrombocytopenia purpura (D69.3) [12] | 31,821 | 54.7 |
Multiple sclerosis (G35) [13] | 87,930 | 69.1 |
Myasthenia gravis (G70.0) [14] | 11,745 | 49.8 |
Myxedema (E03.8 to E03.9) [15] | 941,746 | 80.6 |
Pemphigus (L10) | 2,341 | 57.2 |
Pemphigoid (L12) [16] | 13,585 | 56.1 |
Pernicious anemia (D51.0) | 68,679 | 68.4 |
Polyarteritis nodosa (M30.0) [17] | 2,419 | 44.4 |
Primary biliary cirrhosis (K74.3) [18] | 11,617 | 84.6 |
Psoriasis (L40) [19] | 121,003 | 48.3 |
Rheumatoid arthritis (M05 to M06) [5] | 346,804 | 71.1 |
Scleroderma (M34) [20] | 12,681 | 81.9 |
Sjögren’s syndrome (M35.0) | 18,791 | 88.6 |
Systemic lupus erythematosus (M32.1 to M32.9) [6] | 27,519 | 86.7 |
Thyrotoxicosis (E05) | 133,971 | 78.6 |
Ulcerative colitis (K51) [21] | 191,977 | 48.7 |